Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

FED 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 15Prostatic Neoplasms 14Neoplasms 12Lung Neoplasms 8Colonic Neoplasms 7Colonic Polyps 5Pulmonary Disease, Chronic Obstructive 4Heart Failure 4Urinary Incontinence 2Smoking Cessation 2Patient Preference 2Pain 2Lung Diseases 2Deglutition Disorders 2Death 2Chronic Disease 2Breast Neoplasms 2Adenomatous Polyps 2Adenoma 2Weight Loss 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Tobacco Use 1Tobacco Smoking 1Stress Disorders, Post-Traumatic 1Smoking Reduction 1Skin Neoplasms 1Skin Diseases 1Respiratory Aspiration 1Renal Insufficiency, Chronic 1

Interventions

Selective Serotonin Reuptake Inhibitors 1Methylphenidate 1Citalopram 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
FED × Has results × Mental Disorders × Clear all
NCT00129467 2015-04-24

Methylphenidate for Depressed Cancer Patients Receiving Palliative Care

VA Office of Research and Development

Phase NA Completed
47 enrolled 13 charts

Caregiver Burden, Mental Disorders, Depression, Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡